Prevalence of serum anti-neuronal autoantibodies in patients admitted to acute psychiatric care
- 9 September 2016
- journal article
- research article
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 46 (16), 3303-3313
- https://doi.org/10.1017/s0033291716002038
Abstract
Background: Autoimmune encephalitis associated with anti-neuronal antibodies may be challenging to distinguish from primary psychiatric disorders. The significance of anti-neuronal antibodies in psychiatric patients without clear evidence of autoimmune encephalitis is unknown. We investigated the serum prevalence of six anti-neuronal autoantibodies in a cohort of unselected patients admitted to acute psychiatric care.Method: Serum was drawn from 925 patients admitted to acute psychiatric in-patient care. Psychiatric diagnoses were set according to International Classification of Diseases (ICD)-10 criteria. Antibody analysis was performed with an indirect immunofluorescence test for N-methyl d-aspartate receptor (NMDAR) antibodies and five other anti-neuronal autoantibodies of the immunoglobulin (Ig) classes IgA, IgG and IgM isotype.Results: Anti-neuronal autoantibodies were found in 11.6% of patients: NMDAR antibodies in 7.6%, contactin-associated protein-like 2 (CASPR2) antibodies in 2.5%, glutamic acid decarboxylase-65 (GAD65) antibodies in 1.9%, and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antibodies in 0.1%. Leucine-rich glioma-inactivated protein-1 (LGI1) and γ-aminobutyric acid B (GABAB) receptor antibodies were not detected. NMDAR antibodies of class IgG were present in five patients only (0.5%). NMDAR antibodies of all Ig classes were equally prevalent in patients with and without psychosis. There were no significant differences in antibody prevalence in the different diagnostic categories, except for a higher odds ratio of being NMDAR antibody positive for patients without a specific psychiatric diagnosis.Conclusions: NMDAR IgG autoantibodies, which are known to be strongly associated with anti-NMDAR encephalitis, were rarely found. CASPR2 and GAD65 antibodies were more frequently encountered in the present study than previously reported. Further research on the clinical significance of anti-neuronal autoantibodies in patients with acute psychiatric symptoms is needed.Keywords
This publication has 41 references indexed in Scilit:
- Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis opticaJournal of Neurology, Neurosurgery & Psychiatry, 2016
- Prevalence ofN-Methyl-D-Aspartate Receptor Autoantibodies in the Peripheral BloodJAMA Psychiatry, 2014
- Seroprevalence of autoantibodies against brain antigens in health and diseaseAnnals of Neurology, 2014
- Seroprevalence of n-methyl-d-aspartate glutamate receptor (NMDA-R) autoantibodies in aging subjects without neuropsychiatric disorders and in dementia patientsArchiv Fur Psychiatrie Und Nervenkrankheiten, 2014
- Early recognition of anti-N-methyl D-aspartate (NMDA) receptor encephalitis presenting as acute psychosisAustralasian Psychiatry, 2013
- Increased Prevalence of Diverse N -Methyl-D-Aspartate Glutamate Receptor Antibodies in Patients With an Initial Diagnosis of SchizophreniaJAMA Psychiatry, 2013
- Anti-NMDA Receptor Encephalitis: Diagnosis, Psychiatric Presentation, and TreatmentAmerican Journal of Psychiatry, 2011
- Psychiatric Manifestations of Voltage-Gated Potassium-Channel Complex AutoimmunityThe Journal of Neuropsychiatry and Clinical Neurosciences, 2011
- Acute unstable depressive syndrome (AUDS) is associated more frequently with epilepsy than major depressionBMC Neurology, 2010
- Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodiesThe Lancet Neurology, 2008